|Hosted on behalf of the European Commission|
|EudraCT user manual|
|Registering a trial and updating its information|
|EudraCT number, CTA & Login for posting results|
|CTA & results documentation|
|Tutorials on posting results|
|Frequently asked questions|
|National competent authorities|
|Statistics and technical documentation|
|EU Clinical Trials Register|
|Need Help? Contact us|
Welcome to the EudraCT public home page
EudraCT (European Union Drug Regulating Authorities Clinical Trials Database) is the European database for all interventional clinical trials on medicinal products authorized in the European Union (EEA) and outside the EU/EEA if they are part of a Paediatric Investigation Plan (PIP) from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC. Protocol and results information on interventional clinical trials are made publicly available through the European Union Clinical Trials Register since September 2011.
In order to navigate through the present website, it is strongly encouraged to refer to the EudraCT user manual.
Sponsors’ representatives are recommended to prepare and post clinical trials results as explained in the Tutorials on posting results webpage.
Requirements to provide results for authorised clinical trials: Joint Letter by the European Commission, EMA and HMA
Brexit preparedness: Joint Technical Notice to Sponsors by the European Commission, EMA and HMA
Sponsors of clinical trials on COVID-19 are requested to include the term "COVID-19" in the title of their trial (section A.3 of the CTA). Sponsors are also reminded of the importance of timely reporting of SAEs (Serious Adverse Events) and of SUSARs (Suspected Unexpected Serious Adverse Reactions) to the competent authorities, in order to protect the safety of the participants. In addition, we encourage sponsors of COVID-19 trials to post the relevant results as soon as it is feasible, also before the deadline.
We would like to make Sponsors aware there is an issue with the assignment of primary users of trials.
The statistics for September 2020 are now available.
Sponsors of trials that are "prematurely ended" can now post results in EudraCT as a pdf document.
Please refer to the Tutorials on posting results in order to know how to become a primary user for your trial and post the pdf document. After the document has been uploaded, kindly click on "post results" on the top right corner. The document will be published in EU CTR after 2 weeks from posting date (except for phase 1 trials in adults, that are not publicly available, see FAQs).
The EudraCT website will be unavailable to users today between 6 pm and 8 pm (CET). We apologise for this inconvenience and we thank you very much for your patience.
A new version of the document "Results: modalities and timing of posting" is now available. This document provides more clarity regarding the modality of results posting for trials ended before 21 July 2013 and between 21 July 2013 and 21 July 2014.
Computer application maintenance weekend 19-20 September 2020
The statistics for August 2020 are now available.
The statistics for July 2020 are now available.
The Joint Technical Notice to Sponsors by the European Commission, EMA and HMA was published yesterday on the European Commission health website.
Computer application maintenance Saturday, 11 July 2020
Essential maintenance work will be carried out to all EudraCT applications as part of EMA’s computer application maintenance work this weekend. As a result, EudraCT systems will be intermittently unavailable between 10:00hrs and 13:00hrs of Saturday, 11 July 2020. If you have any questions, please contact the EMA Service Desk.
The statistics for June 2020 are now available.
The frequently asked questions have been updated.
Previous news can be found here
As of 1.2.2020, the UK is no longer an EU Member State. However, EU law still applies to the UK during the transition period.